Clinical Trial Update: Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis

View source ↗

Summary

Completed clinical trial update for Omepral tablets investigating erosive esophagitis (reflux esophagitis) in patients, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• Omepral

Snippet

Sponsor: AstraZeneca | Conditions: Reflux Esophagitis | Status: COMPLETED